#$%^&*AU2013203214A120130502.pdf#####ABSTRACT Disclosed are methods and materials for inhibiting (e.g., treating or preventing) uveitis in a subject, including treatment refractory uveitis, using anti-IL-1 P binding molecules (e.g., IL-1p binding antibodies or binding fragment thereof).